Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings

JE Fugate, DO Claassen, HJ Cloft, DF Kallmes… - Mayo Clinic …, 2010 - Elsevier
OBJECTIVE To identify and define clinical associations and radiologic findings of posterior
reversible encephalopathy syndrome (PRES). PATIENTS AND METHODS Patients …

Predictors of neurologic outcome in hypothermia after cardiac arrest

…, EFM Wijdicks, J Mandrekar, DO Claassen… - Annals of …, 2010 - Wiley Online Library
Objective To evaluate the predictive value of neurologic prognostic indicators for patients
treated with hypothermia after surviving cardiopulmonary arrest. Methods Patients who …

Impulse control and related disorders in Parkinson's disease

D Weintraub, DO Claassen - International review of neurobiology, 2017 - Elsevier
Impulse control disorders (ICDs), such as compulsive gambling, buying, sexual, and eating
behaviors, are a serious and increasingly recognized complication in Parkinson's disease (…

Ultrasound Blood–Brain Barrier Opening and Aducanumab in Alzheimer's Disease

…, A Tarabishy, P Tirumalai, DO Claassen… - … England Journal of …, 2024 - Mass Medical Soc
Antiamyloid antibodies have been used to reduce cerebral amyloid-beta (Aβ) load in
patients with Alzheimer’s disease. We applied focused ultrasound with each of six monthly …

Effect of deutetrabenazine on chorea among patients with Huntington disease: a randomized clinical trial

…, J Jimenez-Shahed, C Hunter, DO Claassen… - Jama, 2016 - jamanetwork.com
Importance Deutetrabenazine is a novel molecule containing deuterium, which attenuates
CYP2D6 metabolism and increases active metabolite half-lives and may therefore lead to …

[HTML][HTML] Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial

…, Y Bordelon, J Bower, J Brosch, D Claassen… - The Lancet …, 2021 - thelancet.com
Background Progressive supranuclear palsy is a neurodegenerative disorder associated with
tau protein aggregation. Tilavonemab (ABBV-8E12) is a monoclonal antibody that binds to …

Predictors of outcome in warfarin-related intracerebral hemorrhage

AY Zubkov, JN Mandrekar, DO Claassen… - Archives of …, 2008 - jamanetwork.com
Background Intracerebral hemorrhage (ICH) associated with warfarin sodium therapy is
becoming more common as the use of this medication increases in the aging population. …

Diffusion along perivascular spaces reveals evidence supportive of glymphatic function impairment in Parkinson disease

…, Y Yan, H Kang, MJ Donahue, DO Claassen - Parkinsonism & related …, 2021 - Elsevier
Background Reduced diffusion along perivascular spaces in adults with Alzheimer's-disease-related-dementias
has been reported and attributed to reduced glymphatic function. …

Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage

DO Claassen, N Kazemi, AY Zubkov… - Archives of …, 2008 - jamanetwork.com
Background Reinitiating warfarin sodium therapy in a patient with a recent warfarin-related
intracerebral hemorrhage (WAICH) is a difficult clinical decision. Therefore, it is important to …

The risky business of dopamine agonists in Parkinson disease and impulse control disorders.

DO Claassen, WPM van den Wildenberg… - Behavioral …, 2011 - psycnet.apa.org
Risk-taking behavior is characterized by pursuit of reward in spite of potential negative
consequences. Dopamine neurotransmission along the mesocorticolimbic pathway is a potential …